Translating breakthroughs in genetics into biomedical innovation: The case of UK Genetic Knowledge Parks

Technology Analysis and Strategic Management

Volumn 19, Issue 2, 2007, Pages 189-204

  Robertson, Maxine ^a  

^a Institute for Clean Growth and Future Mobility   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENETICS; INNOVATION; MEDICINE; SCIENCE AND TECHNOLOGY; TECHNOLOGICAL DEVELOPMENT; TECHNOLOGY POLICY;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 33947281730     PISSN: 09537325     EISSN: 14653990     Source Type: Journal    
DOI: 10.1080/09537320601168136     Document Type: Article

References (66)

1. P. Nightingale & P. Martin, The myth of the biotech revolution, Trends in Biology, March 2004.
2. CMR International, Centre for Medical Research International R&D Compendium 2004 (CMR International, 2004).
3. R. Henderson, L. Orsenigo & G. Pisano, The pharmaceutical industry and the revolution in molecular biology: Interactions among scientific, institutional, and organizational change, in: D. Mowery & R. Nelson (Eds) Sources of Industrial Leadership (Cambridge: Cambridge University Press, 1999), pp. 267-311.
4. C. Christensen, R. Bohmer & J. Kenagy, Will disruptive innovations cure health care? Harvard Business Review, September/October 2000, pp. 102-112.
5. Ibid.
6. S. Dopson, The diffusion of medical innovations: Can configurationally sociology contribute? Organization Studies, 26(8), 2005, pp. 1125-1144.
7. W. Powell, W. Koput & L. Smith-Doerr, Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology, Administrative Science Quarterly, 41(1), 1996, pp. 116-130.
8. D. Hickson, R. Hinings, A. Lee, R. Schneck & J. Pennings, A strategic contingencies' theory of intraorganizational power, Administrative Science Quarterly, 16, 1971, pp. 216-219.
9. C. Hardy, Understanding power: Bringing about strategic change, British Journal of Management, 7, 1996, pp. 3-16.
10. K. Frenken, W. Holzl & F. de Vor, The citation impact of research collaborations: The case of European biotechnology and applied microbiology (1988-2002), Journal of Engineering and Technology Management, 22, 2005, pp. 9-30
11. J. Katz & B. Martin, What is research collaboration? Research Policy, 26, 1997, pp. 1-18.
12. C. Wagner, International linkages: Is collaboration creating a new dynamic for knowledge creation in science? Amsterdam School of Communications Research, University of Amsterdam, The Netherlands, 2002
13. J. Adams, G. Black, J. R. Clemmons & P. Stephan, Scientific teams and institutional collaborations: Evidence from U.S. universities, 1981-1999, Research Policy, 34, 2005, pp. 259-285.
14. D. Archibugi & A. Coco, International partnerships for knowledge in business and academia. A comparison between Europe and the USA, Technovation, 24, 2004, pp. 517-528.
15. A. Oliver, Biotechnology entrepreneurial scientists and their collaborations, Research Policy, 22, 2004, pp. 583-597 (see p. 584).
16. L. Cardinal, T. Alessandri & S. Turner, Knowledge, codifiability, resources and science based innovation, Journal of Knowledge Management, 5(2), 2001, pp. 195-204
17. G. Pisano, Knowledge integration and the locus of learning - an empirical analysis of process-development, Strategic Management Journal, 15, 1994, pp. 85-100.
18. L. Coenen, J. Moodysson & B. Asheim, Nodes, networks and proximities: On the knowledge dynamics of the medicon valley biotech cluster, European Planning Studies, 12(7), 2004, pp. 1003-1018.
19. N. Hara, P. Solomon, S. Kim & D. Sonnenwald, An emerging view of scientific collaboration: Scientists' perspectives on collaboration and factors that affect collaboration, Journal of the American Society for Information Science and Technology, 54(10), 2003, pp. 952-985 (see p. 952).
20. B. Bozeman & E. Corley, Scientists' collaboration strategies: implications for scientific and human capital, Research Policy, 33, 2004, pp. 599-616 (see p. 599).
21. Ibid., p. 600.
22. S. Fuller, Social epistemology, Indiana University Press, 1988
23. N. Stehr, Knowledge, markets and biotechnology, Social Epistemology, 18(4), 2004, pp. 301-314.
24. M. Gibbons, H. Nowotny, C. Limoges, S. Schwartzman, P. Scott & M. Trow, The new production of knowledge: The dynamics of science and research in contemporary society (London: Sage, 1994).
25. J. Brown & P. Duguid, Knowledge and organization: A social practice perspective, Organization Science, 2, 2001, pp. 40-57.
26. Power et al., op. cit., Ref. 6, p. 121.
27. M. Callon, The sociology of an actor-network: The case of the electric vehicle, in: J. Law and A. Rip (Eds), Mapping the Dynamics of Science and Technology (London: Macmillan, 1986).
28. Power et al., op. cit., Ref. 6.
29. J. Swan & H. Scarbrough, The politics of networked innovation, Human Relations, 58(7), 2005, pp. 913-943.
30. Power et al., op. cit., Ref. 6.
31. Hardy, op. cit., Ref. 8.
32. Hickson et al., op. cit., Ref. 7.
33. U. Elg & U. Johannson, Decision-making in inter-firm networks: antecedents, mechanisms and forms, Organisation Studies, 16(2), 1997, pp. 183-214.
34. Callon, op. cit., Ref. 22.
35. S. Lukes, Power: A Radical View (Macmillan, London, 1974).
36. Ibid.
37. D. Purdue, Experiments in the governance of biotechnology: A case study of the U.K. National Consensus Conference, New Genetics and Society, 18, 1999, pp. 79-99.
38. B. Salter & M. Jones, Reforming the governance of human genetics: The politics of public trust, ESRC Innovative Health Technologies Research Programme, Final Report, 2005.
39. Purdue, op. cit., Ref. 32.
40. This research is jointly funded by the ESRC and EPSRC as part of the ESRC Evolution of Business Knowledge Programme.
41. Whilst the author would like to express gratitude for the data shared and acknowledge the contributions of this collaborator, in the interests of GKP anonymity it is not possible to identify this individual.
42. N. K. Denzin, The Research Act (New York: McGraw-Hill, 1988).
43. Cabinet Office, The advisory and regulatory framework for biotechnology: Report from the Government's Review. Office of Science and Technology, 1999.
44. Estimated definite and probable deaths since 1990. Source: CJD surveillance unit 2nd May 2006.
45. M. Jones & B. Salter, The governance of human genetics: Policy discourse and construction of public trust, New Genetics and Society, 22(1), 2003, pp. 21-41.
46. Salter & Jones, op. cit., Ref. 33
47. Cabinet Office, op. cit., Ref. 38.
48. Cabinet Office, op. cit., Ref. 38, p. i.
49. Ibid.
50. Ibid., p. 2.
51. Ibid.
52. Jones & Salter, op. cit., Ref. 40.
53. NHS Plan, 2000, Department of Health, p. 99.
54. Human Genetics Commission Plenary Meeting Minutes, 25 June 2001 (Appendix A: 2), available at http://www.hgc.gov.uk/Client/ document.asp?DocId=54&CAtagoryId=9.
55. W. E. Bijker, T. Highes & T. J. Pinch (Eds), The Social Construction of Technological Systems (London: MIT Press, 1987).
56. Salter & Jones, op. cit., Ref. 33.
57. Jones & Salter, op. cit., Ref. 40, p. 22.
58. Purdue, op. cit., Ref. 32.
59. Hickson et al., op. cit., Ref. 7.
60. Hardy, op. cit., Ref. 8.
61. Purdue, op. cit., Ref. 32.
62. Cabinet Office, op. cit., Ref. 38, p. 21.
63. Purdue, op. cit., Ref. 32.
64. Fuller, op. cit., Ref. 18.
65. Stehr, op. cit., Ref. 18.
66. Bozeman & Corley, op. cit., Ref. 16.